H.B. Fuller to acquire Advanced Medical Solutions for £2.85/share, ~£715M enterprise value

FULLER H B CO

Offer price of 285p per AMS share in cash; total enterprise value £715M.
Pre-synergy EBITDA multiple of 12.9x; expected run-rate synergies of ~$55M by 2031.
Financing via secured ($2.087B) and unsecured ($917M) bridge credit agreements.
Transaction expected to close by end of 2026, subject to shareholder and regulatory approvals.
New medical business unit to represent ~10% of combined revenue and EBITDA.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.